由于甲状腺疾病导致的二次躁狂.

Treatment of depressive symptoms in human immunodeficiency virus-positive patients.

Archives of general psychiatry·1998

The role of drug and alcohol abuse in recent increases in depression in the US.

Psychological medicine·1996

Long-term follow-up after a drug trial for panic disorder.

The British journal of psychiatry : the journal of mental science·1995

Individual psychotherapies for depressed HIV-positive patients.

The American journal of psychiatry·1995

What are the public health implications of subclinical depressive symptoms?

The Psychiatric quarterly·1994

A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.

Journal of clinical psychopharmacology·1993

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

An herbal formula alleviates hyperuricemia: Evidence from network pharmacology and in vivo experiments.

Combinatorial chemistry & high throughput screening·2026

Behavioral and Molecular Effects of Kamikihito and Mesenchymal Stem Cells in a Two-hit Model of Treatment-resistant Depression.

Current neuropharmacology·2026

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Pain research & management·2026

Diffusion tensor imaging in chronic tension-type headache.

Frontiers in pain research (Lausanne, Switzerland)·2026

Multidimensional therapeutic advantages of <i>Smilax glabra</i> (<i>Tufuling</i>)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction.

Frontiers in endocrinology·2026

Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis.

Frontiers in endocrinology·2026

相关实验视频

由于甲状腺疾病导致的二次躁狂.

相关概念视频

Treatment of depressive symptoms in human immunodeficiency virus-positive patients.

The role of drug and alcohol abuse in recent increases in depression in the US.

Long-term follow-up after a drug trial for panic disorder.

Individual psychotherapies for depressed HIV-positive patients.

What are the public health implications of subclinical depressive symptoms?

A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

An herbal formula alleviates hyperuricemia: Evidence from network pharmacology and in vivo experiments.

Behavioral and Molecular Effects of Kamikihito and Mesenchymal Stem Cells in a Two-hit Model of Treatment-resistant Depression.

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Diffusion tensor imaging in chronic tension-type headache.

Multidimensional therapeutic advantages of <i>Smilax glabra</i> (<i>Tufuling</i>)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction.

Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis.

相关实验视频

由于甲状腺疾病导致的二次躁狂.

相关概念视频

相关文章